R M Y Barge

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

Rachel Pawson, Martin J.S. Dyer, R M Y Barge et al. · Journal of Clinical Oncology · 1997 · 209 citations

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

G Hale, Peter Jacobs, L. Wood et al. · Bone Marrow Transplantation · 2000 · 165 citations

Transplant Rejection, Cell Therapy, Graft-versus-host Disease +15

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

Martin B.A. Heemskerk, Suzanna M. van Walraven, J.J. Cornelissen et al. · Bone Marrow Transplantation · 2005 · 87 citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +6

Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience

R M Y Barge, C.W.J. Starrenburg, JH Falkenburg et al. · Bone Marrow Transplantation · 2006 · 57 citations

Cell Therapy, Transplantation, Marrow Transplantation +12

Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation

Jayant Kalpoe, Aloys C.M. Kroes, S Verkerk et al. · Bone Marrow Transplantation · 2006 · 39 citations

Diagnostic Virology, Transplantation, Molecular Virology +7